The well-known pharmaceutical company Forest Laboratories was incorporated in Delaware, with its principal office in New York City. It was founded in 1956 as a small laboratory service company. This company was known for licensing European pharmaceuticals for sale in the United States. It was acquired Actavis on July 1, 2014.
The company had achieved a degree of success in its niche and found a steady demand for its services during the 1950s. Forest Laboratories, Inc. manufactures, develops, and sells branded and generic forms of effective drug products. Its main products are like Lexapro for the treatment of depression in adults and adolescents, and anxiety disorder in adults; Namenda for the treatment of Alzheimer's disease; Bystolic for the treatment of hypertension; and Savella for the management of fibromyalgia.
The company has its own business strategy that involves three elements such as licensing promising new compounds from innovative companies worldwide, conducting rigorous scientific investigation & development of unique, highly effective drug therapies, and executing marketing or sales initiatives to establish products in the industry.